Icon, Varian Partner to Expand Cancer Tech Access in the UK
Icon Group, a global leader in integrated cancer care, has announced a significant new agreement with Varian, a Siemens Healthineers company, involving an investment of...
Tag : Boost Cancer Care
ASCO GU: Veracyte’s Decipher Tests Boost Cancer Care, Research
Study showing that Decipher GRID-derived PORTOS signature predicts benefit from dose-escalated radiation therapy also published in Annals of Oncology Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics...